| 000 | 01933 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514213337.0 | ||
| 264 | 0 | _c20050930 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-04-1106 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStewart, A Keith | |
| 245 | 0 | 0 |
_aResults of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cDec 2004 |
||
| 300 |
_a8170-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xtherapy |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aStem Cell Transplantation |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aThalidomide _xadministration & dosage |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChen, Christine I | |
| 700 | 1 | _aHowson-Jan, Kang | |
| 700 | 1 | _aWhite, Darrell | |
| 700 | 1 | _aRoy, Jean | |
| 700 | 1 | _aKovacs, Michael J | |
| 700 | 1 | _aShustik, Chaim | |
| 700 | 1 | _aSadura, Anna | |
| 700 | 1 | _aShepherd, Lois | |
| 700 | 1 | _aDing, Keyue | |
| 700 | 1 | _aMeyer, Ralph M | |
| 700 | 1 | _aBelch, Andrew R | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 10 _gno. 24 _gp. 8170-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-04-1106 _zAvailable from publisher's website |
| 999 |
_c15304292 _d15304292 |
||